PHI with Familial osteochondromatosis
How does this condition affect your private health insurance?
Familiäre Osteochondromatose, also known as Multiple Hereditary Exostoses (MHE), is a rare genetic disorder characterized by the development of multiple benign bone tumors (osteochondromas) that grow outward from the bone surface, usually near the growth plates. These growths typically appear in childhood and adolescence, ceasing at skeletal maturity. While benign, they can cause pain, limb deformities, restricted joint movement, nerve or blood vessel compression, and in rare cases, undergo malignant transformation into chondrosarcoma. The condition varies widely in severity among affected individuals.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 25%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Manifestations typically begin in early childhood or adolescence, presenting as palpable lumps or bone deformities. The process of new exostosis formation continues until skeletal maturity.
Duration of Illness (Lifetime)
A lifelong, chronic genetic condition. Exostoses typically stop growing at skeletal maturity, but complications and the risk of malignant transformation persist.
Cost of Treatment (Initial)
Initial diagnostic imaging (X-rays, MRI), specialist consultations (orthopedics, genetics), and potentially early surgical removal of problematic exostoses. Costs can range from several hundred to several thousand Euros/Dollars, depending on complexity and location.
Cost of Treatment (Lifetime)
Involves lifelong monitoring, repeated imaging, multiple surgical procedures to remove symptomatic exostoses or correct deformities, physical therapy, pain management, and potentially oncology treatment if malignant transformation occurs. Lifetime costs can be substantial, ranging from tens of thousands to hundreds of thousands of Euros/Dollars.
Mortality Rate
Very low, primarily associated with complications from malignant transformation (chondrosarcoma), which occurs in 1-5% of cases. Otherwise, it is not directly life-threatening.
Risk of Secondary Damages
High. Includes chronic pain, skeletal deformities (e.g., limb length discrepancies, angular deformities), restricted joint range of motion, nerve compression (e.g., peripheral neuropathy), vascular compression, tendon irritation, and the risk (1-5%) of malignant transformation into chondrosarcoma.
Probability of Full Recovery
Essentially 0%. It's a genetic condition where the osteochondromas are a physical manifestation. While symptoms can be managed and exostoses removed, the underlying genetic predisposition and the potential for new or recurrent issues remain throughout life.
Underlying Disease Risk
Familiäre Osteochondromatose is a primary genetic disorder (autosomal dominant, usually involving EXT1 or EXT2 genes). There are no 'underlying diseases' that cause MHE. However, individuals with MHE have an increased probability of developing complications such as chronic pain (high), osteoarthritis (moderate to high), nerve compression syndromes (moderate), vascular compromise (low), and malignant transformation to chondrosarcoma (1-5%).